Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Aug 27, 2026; 18(8): 121272
Published online Aug 27, 2026. doi: 10.4240/wjgs.121272
Published online Aug 27, 2026. doi: 10.4240/wjgs.121272
Table 2 Baseline demographic and clinical characteristics stratified by inflammation/nutrition-based combined score, median (interquartile range)/n (%)
| Variable | Total (n = 154) | Low score (0-3, n = 121) | High score (4-6, n = 33) | P value |
| Age (years) | 68 (61-76) | 67 (60-74) | 75 (70-83) | < 0.001a |
| Sex (male) | 96 (62.3) | 78 (64.5) | 18 (54.5) | 0.401 |
| Type of surgery | 0.050 | |||
| Subtotal | 59 (38.3) | 41 (33.9) | 18 (54.5) | |
| Total | 95 (61.7) | 80 (66.1) | 15 (45.5) | |
| Neoadjuvant chemotherapy | 29 (18.8) | 25 (20.7) | 4 (12.1) | 0.389 |
| Overall mortality | 94 (61.0) | 65 (53.7) | 29 (87.9) | < 0.001a |
| TNM stage | n = 151 | 0.016a | ||
| Stage I | 19 (12.6) | 18 (14.9) | 1 (3.0) | |
| Stage II | 45 (29.8) | 39 (32.2) | 6 (18.2) | |
| Stage III | 65 (43.0) | 48 (39.7) | 17 (51.5) | |
| Stage IV | 22 (14.6) | 13 (10.7) | 9 (27.3) | |
| Perineural invasion | 107/153 (69.9) | 79 (65.3) | 28 (84.8) | 0.058 |
| Differentiation (poor) | n = 108 | 0.136 | ||
| Poor | 48 (44.4) | 36 (29.8) | 12 (36.4) | |
| Moderate | 43 (39.8) | 30 (24.8) | 13 (39.4) | |
| Good | 17 (15.7) | 16 (13.2) | 1 (3.0) |
- Citation: Çanakcı MH, Kayılıoğlu I, Şimşek A, Dinç T. Combined inflammation/nutrition-based prognostic score for overall survival in gastric adenocarcinoma: A retrospective cohort study. World J Gastrointest Surg 2026; 18(8): 121272
- URL: https://www.wjgnet.com/1948-9366/full/v18/i8/121272.htm
- DOI: https://dx.doi.org/10.4240/wjgs.121272